TSP1-producing B cells show immune regulatory property and suppress allergy-related mucosal inflammation
Specific immunotherapy (SIT) is the only specific remedy for the treatment of allergic diseases currently. B cells are important immune cells in the immunity. The role of B cells in immune regulatory activities has not been fully understood yet. This study aims to elucidate the role of the thrombosp...
Saved in:
Published in | Scientific reports Vol. 3; no. 1; p. 3345 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
26.11.2013
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Specific immunotherapy (SIT) is the only specific remedy for the treatment of allergic diseases currently. B cells are important immune cells in the immunity. The role of B cells in immune regulatory activities has not been fully understood yet. This study aims to elucidate the role of the thrombospondin (TSP)1-producing B cells in the immune regulatory role of SIT. The results showed that after SIT, the frequency of CD35
+
B cells was increased in the intestine of mice with food allergy. The CD35
+
B cells expressed TSP1 after exposure to specific antigens. Co-culture with the TSP1-producing CD35
+
B cells decreased the levels of CD80/CD86 in dendritic cells; the cells convert naïve CD4
+
T cells to regulatory T cells to inhibit allergic inflammation in the intestine. |
---|---|
ISSN: | 2045-2322 2045-2322 |
DOI: | 10.1038/srep03345 |